When attention-deficit/hyperactivity disorder co-occurs with anxiety disorders: effects on treatment

References

• Newcorn JH, Miller SR, Ivanova I et al. Adolescent outcome of ADHD: impact of childhood conduct and anxiety disorders. CNS Spectr.9, 668–678 (2004).
   PubMed Web of Science ®Google Scholar
• Pliszka SR, Carlson C, Swanson JM. Anxiety disorders. In: ADHD with Comorbid Disorders: Clinical Assessment and Management. Guilford, NY, USA 165–185 (1999).
   Google Scholar
• Tannock R. Attention deficit disorders with anxiety disorders. In: Subtypes of Attention Disorders in Children, Adolescents, and Adults. Brown TE (Ed.). American Psychiatric Press, DC, USA (2000).
   Google Scholar
• Jensen PS, Martin D, Cantwell DP. Comorbidity in ADHD: implications for research, practice, and DSM-V. J. Am. Acad. Child. Adolesc. Psychiatry36, 1065–1079 (1997).
   PubMed Web of Science ®Google Scholar
• Souza I, Pinheiro MA, Mattos P. Anxiety disorders in an attention-deficit/hyperactivity disorder clinical sample. Arq. Neuropsiquiatr.63, 407–409 (2005).
   PubMed Web of Science ®Google Scholar
• Busch B, Biederman J, Cohen LG, Sayer JM, Monuteaux MC, Mick E. Correlates of ADHD among children in pediatric and psychiatric clinics. Psychiatric Services53, 1102–1111 (2002).
   Google Scholar
• Safren SA. Prevalence of childhood ADHD among patients with generalized anxiety disorder and a comparison condition, social phobia. Depress. Anxiety13, 190–191 (2001).
   PubMed Web of Science ®Google Scholar
• Vance A, Costin J, Barnett R, Luk E, Maruff P, Tonge B. Characteristics of parent- and child-reported anxiety in psychostimulant medication naive clinically referred children with attention deficit hyperactivity disorder, combined type (ADHD-CT). Aust. NZ J. Psychiatry36, 234–239 (2002).
   PubMed Web of Science ®Google Scholar
• Pliszka SR. Comorbidity of attention-deficit hyperactivity disorder and overanxious disorder. J. Am. Acad. Child. Adolesc. Psychiatry31, 197–203 (1992).
   PubMed Web of Science ®Google Scholar
• Power TJ, Costigan TE, Eiraldi RB, Leff SS. Variations in anxiety and depression as a function of ADHD subtype by DSM-IV: do subtype differences exist or not? J. Abnorm. Child. Psychol.32, 27–37(2004).
   PubMed Web of Science ®Google Scholar
• Manassis K, Tannock R, Young A, Francis-John S. Cognition in anxious children with attention deficit hyperactivity disorder: a comparison with clinical and normal children. Behav. Brain Funct.3, 4 (2007).
   PubMedGoogle Scholar
• MTA Cooperative Group. Moderators and mediators of treatment response for children with ADHD. Arch. Gen. Psychiatry56, 1088–1096 (1999).
   PubMed Web of Science ®Google Scholar
• Brown TE. ADHD with anxiety disorders. In: Attention-Deficit Disorders and Comorbidities in Children, Adolescents, and Adults. American Psychiatric Press, DC, USA 80–105 (2000).
   Google Scholar
• Jensen PS, Hinshaw SP, Kraemer HC, Lenora N, Newcorn JH, Abikoff HB. ADHD comorbidity findings form the MTA study: comparing comorbid subgroups. J. Am. Acad. Child. Adolesc. Psychiatry40, 147–158 (2001).
   PubMed Web of Science ®Google Scholar
• Sanders M, Arduca Y, Karamitsios M, Boots M, Vance A. Characteristics of anxiety disorders in medication naive, clinically referred children with attention deficit hyperactivity disorder, combined type (ADHD–CT) and dysthymic disorder (DD). Aust. NZ J. Psychiatry39, 359–365 (2005).
   PubMed Web of Science ®Google Scholar
• Vance A. Stimulant medication response in ADHD and comorbid anxiety disorder. In: Handbook of ADHD. Bellgrove M, Fitzgerald M, Gill M (Eds). Wiley, IN, USA 331–334 (2007).
   Google Scholar
• Levy F. Synaptic gating and ADHD: a biological theory of comorbidity of ADHD and anxiety. Neuropsychopharm.29, 1589–1596 (2004).
   PubMed Web of Science ®Google Scholar
• Manassis K, Tannock R, Barbosa J. Dichotic listening and response inhibition in children with comorbid anxiety disorders and ADHD. J. Am. Acad. Child. Adolesc. Psychiatry39, 1152–1159 (2000).
   PubMed Web of Science ®Google Scholar
• Perrin S, Last CG. Relationship between ADHD and anxiety in boys: results from a family study. J. Am. Acad. Child. Adolesc. Psychiatry35, 988–996 (1996).
   PubMed Web of Science ®Google Scholar
• Braaten EB, Biederman J, Monuteaux MC et al. Revisiting the association between attention-deficit/hyperactivity and anxiety disorders: a family risk analysis. Biol. Psychiatry53, 93–99 (2003).
   PubMed Web of Science ®Google Scholar
• Pfiffner LJ, McBurnitt K. Family correlates of comorbid anxiety disorders in children with attention deficit/hyperactivity disorder. J. Abnorm. Child. Psychol.34, 725–735 (2006).
   PubMed Web of Science ®Google Scholar
• Pliszka SR, Maas JW, Javors MA, Rogeness GA, Baker J. Urinary catecholamines in attention-deficit hyperactivity disorder with and without comorbid anxiety. J. Am. Acad. Child. Adolesc. Psychiatry33, 1165–1173 (1994).
   PubMed Web of Science ®Google Scholar
• Vance AL, Luk ES. Attention deficit hyperactivity disorder and anxiety: is there an association with neurodevelopmental deficits? Aust. NZ J. Psychiatry32, 650–657 (1998).
   PubMed Web of Science ®Google Scholar
• Vance A. ADHD, combined type in primary school age children: investigations of its association with oppositional defiant, dysthymic and anxiety disorders. In: Attention Deficit Hyperactivity Disorder (ADHD) Research. Larimer MP (Ed.). Nova Press, NY, USA 59–94 (2005).
   Google Scholar
• Schatz DB, Rostain AL. ADHD with comorbid anxiety: a review of the current literature. J. Attention Dis.10, 141–149 (2006).
   PubMedGoogle Scholar
• Vasey MW, Dagleish T, Silverman WK. Research on information-processing factors in child and adolescent psychopathology: a critical commentary. J. Clin. Child. Adolesc. Psychol.32, 81–93 (2003).
   PubMed Web of Science ®Google Scholar
• Oosterlaan J. Response inhibition and response re-engagement in attention deficit/hyperactivity disorder, disruptive, anxious, and normal children. Behav. Brain Res.94, 33–43 (1998).
   PubMed Web of Science ®Google Scholar
• Oosterlaan J, Seargeant JA. Response inhibition in AD/HD, CD, comorbid AD/HD and CD, anxious, and control children: a meta-analysis of studies with the stop task. J. Child Psychol. Psychiatry39, 411–425 (1998).
   PubMed Web of Science ®Google Scholar
• Korenblum CB, Chen SX, Manassis K, Schachar RJ. Performance monitoring and response inhibition in anxiety with and without comorbid ADHD. Depress. Anxiety24(4), 227–232 (2007).
   PubMed Web of Science ®Google Scholar
• Eslinger PJ. Conceptualizing, describing, and measuring components of executive function: a summary. In: Attention, Memory, and Executive Function. Lyon GR, Krasnegor NA (Eds). Paul H Brookes Publishing, MD, USA (1996).
   Google Scholar
• Pliszka SR. Effect of anxiety on cognition, behavior, and stimulant response in ADHD. J. Am. Acad. Child. Adolesc. Psychiatry28, 882–887 (1989).
   PubMed Web of Science ®Google Scholar
• Tannock R, Ickowicz A, Schachar R. Differential effects of methylphenidate on working memory in ADHD children with and without anxiety. J. Am. Acad. Child. Adolesc. Psychiatry34, 886–896 (1995).
   PubMed Web of Science ®Google Scholar
• Eysenck MW, Calvo MG. Anxiety and performance: the processing efficiency theory. Cogn. Emot.6, 409–434 (1992).
   Web of Science ®Google Scholar
• Martinussen R, Hayden J, Hogg-Johnson S, Tannock R. A meta-analysis of working memory impairments in children with attention-deficit/hyperactivity disorder. J. Am. Acad. Child. Adolesc. Psychiatry44, 377–384 (2005).
   PubMed Web of Science ®Google Scholar
• Carlson CL, Mann M. Sluggish cognitive tempo predicts a different pattern of impairment in attention deficit/hyperactivity disorder, predominantly inattentive type. J. Clin. Child. Adolesc. Psychol.31, 123–129 (2002).
   PubMed Web of Science ®Google Scholar
• Hartmann CA, Willcutt WG, Rhee SH, Pennington BF. The relationship between sluggish cognitive tempo and DSM IV ADHD. J. Abnorm. Child. Psychol.35, 491–503 (2004).
   Google Scholar
• March JS, Swanson JM, Arnold EL, Hoza B, Conners CK, Hinshaw SP. Anxiety as a predictor and outcome variable in the multimodal treatment study of children with ADHD (MTA). J. Abnorm. Child. Psychol.28, 527–541 (2000).
   PubMed Web of Science ®Google Scholar
• Diamond IR, Tannock R, Schachar RJ. Response to methylphenidate in children with ADHD and comorbid anxiety. J. Am. Acad. Child. Adolesc. Psychiatry38, 402–409 (1999).
   PubMed Web of Science ®Google Scholar
• Walkup JT, Labellarte MJ, Riddle MA et al. Searching for moderators and mediators of pharmacological treatment in children and adolescents with anxiety disorders. J. Am. Acad. Child. Adolesc. Psychiatry42, 13–21 (2003).
   PubMed Web of Science ®Google Scholar
• Abikoff H, McGough J, Vitiello B et al. Sequential pharmacotherapy for children with comorbid attention-deficit hyperactivity and anxiety disorders. J. Am. Acad. Child. Adolesc. Psychiatry44, 418–427 (2005).
   PubMed Web of Science ®Google Scholar
• Mohammadi MR, Akhondzadeh S. Pharmacotherapy of attention-deficit/hyperactivity disorder: nonstimulant medication approaches. Expert Rev. Neurother.7, 195–201 (2007).
   PubMedGoogle Scholar
• Prasad S, Harpin V, Poole L et al. A multi-centre randomised, open-label study of atomoxetine compared with standard current therapy in UK children and adolescents with attention-deficit/hyperactivity disorder. Curr. Med. Res. Opin.23, 379–394 (2007).
   PubMed Web of Science ®Google Scholar
• Perwien AR, Kratochvil CJ, Faries DE et al. Atomoxetine treatment in children and adolescents with attention-deficit/ hyperactivity disorder: what are the long-term health-related quality of life outcomes? J. Child. Adolesc. Psychopharmacol.16, 713–724 (2006).
   PubMed Web of Science ®Google Scholar
• Troost PW, Steenhuis MP, Tuynman-Qua HG et al. Atomoxetine for attention-deficit/hyperactivity disorder symptoms in children with pervasive developmental disorders: a pilot study. J. Child. Adolesc. Psychopharmacol.16, 611–619 (2006).
   PubMed Web of Science ®Google Scholar
• Kratchovill CJ, Newcorn JH, Arnold LE et al. Atomoxetine alone or combined with fluoxetine for treating ADHD with comorbid depressive or anxiety symptoms. J. Am. Acad. Child. Adolesc. Psychiatry44, 915–924 (2005).
   PubMed Web of Science ®Google Scholar
• Kendall PC, Flannery-Schroeder E, Panichelli-Mindel SM, Southam-Gerow M, Heni M. Therapy for youths with anxiety disorders: a second randomized clinical trial. J. Consult. Clin. Psychol.65, 366–380 (1997).
   PubMed Web of Science ®Google Scholar
• Manassis K, Mendlowitz SL, Scapillato D et al. Group and individual cognitive–behavioral therapy for childhood anxiety disorders: a randomized trial. J. Am. Acad. Child. Adolesc. Psychiatry41, 1423–1430 (2002).
   PubMed Web of Science ®Google Scholar
• Southam-Gerow MA, Kendall PC, Weersing VR. Examining outcome variability: correlates of treatment response in an adolescent anxiety clinic. J. Clin. Child. Psychol.30, 422–436 (2001).
   PubMed Web of Science ®Google Scholar
• Manassis K. Keys to Parenting Your Anxious Child. Barron’s Educational, NY, USA (1996).
   Google Scholar
• Steele M, Jensen PS, Quinn DM. Remission versus response as the goal of therapy in ADHD: a new standard for the field? Clin. Ther.28, 1892–1908 (2006).
   PubMed Web of Science ®Google Scholar
• Cobham VE, Dadds MR, Spence SH. The role of parental anxiety in the treatment of childhood anxiety. J. Consult. Clin. Psychol.66, 893–905 (1998).
   PubMed Web of Science ®Google Scholar
• Manassis K, Monga S. A therapeutic approach to children and adolescents with anxiety disorders and associated comorbid conditions. J. Am. Acad. Child. Adolesc. Psychiatry40, 115–117 (2001).
   PubMed Web of Science ®Google Scholar
• McClure EB, Monk CS, Nelson EE et al. Abnormal attention modulation of fear circuit functioning in pediatric generaliezd anxiety disorder. Arch. Gen. Psychiatry64, 97–106 (2007).
   PubMed Web of Science ®Google Scholar
• Chorpita BF. Modular Cognitive Behavioral Therapy for Childhood Anxiety Disorders. Guilford, NY, USA (2007).
   Google Scholar